Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study suggests 30-day survival benefit from endovascular surgery for treatment of aortic aneurysm

26.08.2004


Early results of a UK study published online today by THE LANCET (Wednesday 25 August 2004) suggest that a surgical procedure to repair aortic aneurysm that is less invasive than conventional open surgery could reduce death within a month of surgery by around two-thirds.

Abdominal Aortic Aneurysm (AAA) is a dangerous swelling of the abdominal aorta which has an increased chance of rupture if it is larger than 5•5cm—a majority of people die from ruptures. The cause of AAA is complex, including atherosclerosis,smoking, and a genetic predisposition.

Surgeons have perfected a new method for treating AAA’s over the past decade, called endovascular repair, or EVAR. In this procedure, 2 small incisions are made in the groin, and a graft is passed through the arteries under Xray control and fixed with a stent which holds the graft in place; this procedure is much less invasive than conventional surgery which requires a deep abdominal incision.



41 UK hospitals collaborated in the study, providing a surgical and radiological team to investigate whether EVAR is as good or better than conventional open surgery. More than 1000 patients with large (5•5 cm or greater) AAA (all of whom were over 60 years of age, and over 90% of whom were men) were randomly allocated to receive either EVAR or conventional open surgery. The death rate within 30 days of surgery was reduced by around two-thirds compared with patients given open surgery (1•7% and 4•7% mortality rates, respectively); however, there were 75% more secondary procedures done among patients initially given EVAR.

Investigator Roger Greenhalgh (Imperial College London, and Hammersmith Hospitals NHS Trust, UK) comments: “These early results with EVAR, applied to large aneurysms in suitable patients, provide justification for continued use of this technique in controlled or trial settings; however, the early promise of endovascular repair cannot be guaranteed and might not endure in the long term. These 30-day mortality results are a licence to continue scientific evaluation of EVAR, but not to change clinical practice. He adds: “The NHS is the perfect vehicle to do research of this type, but it is entirely dependent on the determination of a group of doctors—as in this case—to overcome clinical uncertainty to be able to offer their patients the best possible treatment.”

Richard Lane | alfa
Further information:
http://www.lancet.com

More articles from Studies and Analyses:

nachricht Real-time feedback helps save energy and water
08.02.2017 | Otto-Friedrich-Universität Bamberg

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

New pop-up strategy inspired by cuts, not folds

27.02.2017 | Materials Sciences

Sandia uses confined nanoparticles to improve hydrogen storage materials performance

27.02.2017 | Interdisciplinary Research

Decoding the genome's cryptic language

27.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>